🔥🐔 BizChicken 🐔🔥
Companies Similar to Cassava Sciences, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
CASI Pharmaceuticals, Inc.
EVOMELA
CASI Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes therapeutics and pharmaceutical products focusing on markets in China, the United States, and internationally. Major products include EVOMELA and a pipeline with several investigational products targeting various cancers.
About | About | Contact | Contact | Contact | Careers | Careers | Careers | Jobs | Careers | About
Symbol: CASI
Recent Price: $2.93
Industry: Biotechnology
CEO: Dr. Wei-Wu He Ph.D.
Sector: Healthcare
Employees: 176
Address: 9620 Medical Center Drive, Rockville, MD 20850
Phone: 240 864 2600
Last updated: 2024-12-31
Biogen Inc.
TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, FAMPYRA, SPINRAZA, FUMADERM, BENEPALI, ADUHELM, IMRALDI, FLIXABI, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS
Biogen Inc. focuses on discovering, developing, manufacturing, and delivering therapies for neurological and neurodegenerative diseases, including multiple sclerosis, spinal muscular atrophy, plaque psoriasis, Alzheimer's disease, and various cancers and autoimmune conditions.
About | About | Vision/Values | Leadership | Foundation | Contact | Careers | Careers | Careers | Careers | Careers | About | About | Careers | Careers | Careers | Careers | Benefits | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: BIIB
Recent Price: $150.19
Industry: Drug Manufacturers - General
CEO: Mr. Christopher A. Viehbacher
Sector: Healthcare
Employees: 7570
Address: 225 Binney Street, Cambridge, MA 02142
Phone: 617 679 2000
Leadership
- Christopher A. Viehbacher, President and Chief Executive Officer
- Susan H. Alexander, Chief Legal Officer
- Ginger Gregory, Ph.D., Chief Human Resources Officer
- Jane Grogan, Ph.D., Head of Research
- Rachid Izzar, Head of Global Product Strategy & Commercialization
- Adam Keeney, Head of Corporate Development
- Michael McDonnell, Chief Financial Officer
- Nicole Murphy, Head of Pharmaceutical Operations and Technology
- Priya Singhal, M.D., M.P.H., Head of Development and Interim Chief Medical Officer
- Alisha Alaimo, President, Head of North America
- Stephen Amato, Head of Investor Relations
- Natacha Gassenbach, Head of Corporate Affairs, Chief Communications Officer
- Fraser Hall, President, Head of Intercontinental Region
- Wolfram Schmidt, President, Head of Europe
- Kendra Thomas, Head of Global Workforce Diversity, Equity & Inclusion (DE&I)
- Caroline Dorsa, Chair of the Board
- Maria C. Freire, Ph.D., Director
- William A. Hawkins, Director
- Susan Langer, Director
- Jesus B. Mantas, Director
- Lloyd B. Minor, M.D., Director
- Monish Patolawala, Director
- Eric K. Rowinsky, M.D., Director
- Stephen A. Sherwin, M.D., Director
Last updated: 2024-12-31
Fulcrum Therapeutics, Inc.
losmapimod and FTX-6058
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing products to improve the lives of patients with genetically defined diseases in areas of high unmet medical need in the United States.
Symbol: FULC
Recent Price: $4.68
Industry: Biotechnology
CEO: Mr. Alexander C. Sapir
Sector: Healthcare
Employees: 76
Address: 26 Landsdowne Street, Cambridge, MA 02139
Phone: 617 651 8851
Last updated: 2024-12-31
Alto Neuroscience, Inc.
ALTO-100, ALTO-300, ALTO-101, ALTO-203, ALTO-202
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company specializing in psychiatry drug development, with a range of innovative treatments targeting major depressive disorder and cognitive impairments.
Symbol: ANRO
Recent Price: $4.20
Industry: Biotechnology
CEO: Dr. Amit Etkin M.D., Ph.D.
Sector: Healthcare
Employees: 78
Address: 369 South San Antonio Road, Los Altos, CA 94022
Phone: (650) 200-0412
Last updated: 2024-12-31
Absci Corporation
Integrated Drug Creation Platform
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using an integrated drug creation platform for partners in the United States. Its platform enables the creation of biologics by unifying the drug discovery and cell line development processes.
About | About | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About
Symbol: ABSI
Recent Price: $2.65
Industry: Biotechnology
CEO: Mr. Sean McClain
Sector: Healthcare
Employees: 155
Address: 18105 SE Mill Plain Boulevard, Vancouver, WA 98683
Phone: 360 949 1041
Last updated: 2024-12-31
Abivax SA American Depositary Shares
obefazimod
ABIVAX Société Anonyme is a clinical-stage biotechnology company developing therapeutics to modulate the immune response for chronic inflammatory diseases. Their lead drug candidate, obefazimod, is in Phase 3 clinical trials for ulcerative colitis.
About | Vision/Values | History | Leadership | Contact | About | About
Symbol: ABVX
Recent Price: $7.05
Industry: Biotechnology
CEO: Mr. Marc M. P. de Garidel M.B.A.
Sector: Healthcare
Employees: 62
Address: 7-11 boulevard Haussmann, Paris, null 75009
Phone: 33 1 53 83 09 63
Leadership
- Marc de Garidel, MBA, Chief Executive Officer
- Didier Blondel, EVP, Chief Financial Officer & Board Secretary
- Fabio Cataldi, MD, Chief Medical Officer
- Ida Hatoum, Chief People Officer, Chief Compliance Officer
- David Zhang, PhD, Chief Strategy Officer
- Pierre Courteille, Pharmacist, MBA, Chief Business Officer
- Didier Scherrer, PhD, Chief Scientific Officer
- Jérôme Denis, PhD, EVP, Process Development & Manufacturing
- Nadège Briancon-Eris, PhD, Senior Vice President, Global Head of Program Management
- Sylvie Grégoire, PharmD, Chair of the Board
- Corinna zur Bonsen-Thomas, Co-founder and CEO of RetInSight; Former General Counsel at Baxter/Baxalta International
- Philippe Pouletty, MD, Founder of Abivax; Managing Partner of Truffle Capital
- June Lee, MD FACCP, Venture Partner at 5AM Ventures
- Kinam Hong, MD, MBA, CFA, Partner at the Crossover Fund Sofinnova
- Troy Ignelzi, CFO of Rapport Therapeutics
- Camilla Soenderby, Board Member of BB Biotech, F2G, and Affibody; Member of Novo Holdings Advisory Group; Industrial Advisor for EQT
- Mary Mantock, Senior Vice President, Global Head of Regulatory Affairs
- Hema Keshava, Senior Vice President, Finance
- Cristina Damatarca, MD, PgD, Senior Vice President, Global Head of Drug Safety and Pharmacovigilance
- Patrick Malloy, Senior Vice President, Investor Relations
- Douglas Jacobstein, MD, Senior Vice President, Global Head of Clinical Development
- Jennifer Fine, ScD, Senior Vice President, Global Head of HEOR and RWE
- Kevin Shan, PhD, Vice President, Global Head of Biometrics
- Chris Rabbat, PhD, Vice President, Global Head of Medical Affairs
- Ana Sharma, MPH, Vice President, Global Head of Quality
- Sophie LaCourrege, Vice President, HR Business Partner, Engagement and Culture
Last updated: 2024-12-31
Alzamend Neuro, Inc.
AL001 and AL002
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing products for neurodegenerative and psychiatric disorders. Their pipeline includes AL001 for Alzheimer's and psychiatric disorders, and AL002 for Alzheimer's disease using a novel vaccine approach.
About | About | Contact | Contact | Contact | Contact | Careers | About | About | About | About | About
Symbol: ALZN
Recent Price: $1.20
Industry: Biotechnology
CEO: Mr. Stephan Jackman
Sector: Healthcare
Employees: 4
Address: 3500 Lenox Road NE, Atlanta, GA 30326
Phone: 844 722 6333
Last updated: 2024-12-31
BioVie Inc.
BIV201, NE3107
Bio Vie Inc., a clinical stage biotechnology company, focuses on discovering, developing, and commercializing drug therapies in the United States, with products targeting liver cirrhosis, Alzheimer's, Parkinson's, multiple myeloma, and prostate cancer.
Symbol: BIVI
Recent Price: $2.09
Industry: Biotechnology
CEO: Mr. Cuong Viet Do M.B.A.
Sector: Healthcare
Employees: 14
Address: 680 West Nye Lane, Carson City, NV 89703
Phone: 775 888 3162
Last updated: 2024-12-31
Curis, Inc.
Emavusertib
Curis, Inc. is a biotechnology company focused on discovering and developing drug candidates for treating human cancers, with a range of clinical stage and pipeline products targeting lymphomas, leukemia, and solid tumors.
About | Management | Directors | About | About | Contact | Contact | Contact | About | Careers | Careers | Benefits | About | About | About | About | Jobs | About
Symbol: CRIS
Recent Price: $3.14
Industry: Biotechnology
CEO: Mr. James E. Dentzer
Sector: Healthcare
Employees: 49
Address: Building C, Lexington, MA 02421
Phone: 617 503 6500
Leadership
- Martyn D. Greenacre, Chair of the Board
- John Hohneker, M.D., Director
- Kenneth I. Kaitin, Ph.D., Director
- Anne E. Borgman, M.D., Director
- Marc Rubin, M.D., Director
- James Dentzer, Chief Executive Officer and Director
Last updated: 2024-12-31
CervoMed Inc.
neflamapimod
Cervo Med Inc. is a clinical-stage biotechnology company focused on developing and commercializing drug treatments for neurodegenerative diseases, including neflamapimod for conditions like dementia with Lewy bodies, Alzheimer's diseases, and brain stroke recovery.
Symbol: CRVO
Recent Price: $2.39
Industry: Biotechnology
CEO: Dr. John J. Alam M.D.
Sector: Healthcare
Employees: 8
Address: 20 Park Plaza, Boston, MA 02116
Phone: 617-744-4400
Last updated: 2024-12-31
Cyclacel Pharmaceuticals, Inc.
Fadraciclib, CYC140, Sapacitabine, Seliciclib
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of medicines for treating cancer and other proliferative diseases. The company's key development programs include fadraciclib, CYC140, Sapacitabine, and seliciclib, targeting various forms of cancer and other conditions.
Symbol: CYCC
Recent Price: $0.37
Industry: Biotechnology
CEO: Mr. Spiro George Rombotis
Sector: Healthcare
Employees: 12
Address: 200 Connell Drive, Berkeley Heights, NJ 07922
Phone: 908 517 7330
Last updated: 2024-12-31
Cyclo Therapeutics, Inc.
Trappsol Cyclo
Cyclo Therapeutics, Inc. is a clinical stage biotechnology company focused on developing cyclodextrin-based products for various diseases, with its lead drug candidate Trappsol Cyclo undergoing Phase III trials for Niemann-Pick Type C disease and exploration for Alzheimer's treatment.
Contact | Contact | News | About | About | About | About | About | About | About | About | About | Careers | About | About | About
Symbol: CYTH
Recent Price: $0.60
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. N. Scott Fine
Sector: Healthcare
Employees: 8
Address: 6714 NW 16th Street, Gainesville, FL 32653
Phone: 386 418 8060
Last updated: 2024-12-31
Immunic, Inc.
IMU-838
Immunic, Inc. develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, in Phase 2 clinical trials for multiple conditions, including relapsing-remitting multiple sclerosis.
About | Vision/Values | Contact | Contact | Contact | Careers | About | About | About | About | About
Symbol: IMUX
Recent Price: $1.03
Industry: Biotechnology
CEO: Dr. Daniel Vitt Ph.D.
Sector: Healthcare
Employees: 85
Address: 1200 Avenue of the Americas, New York, NY 10036
Phone: 332 255 9818
Last updated: 2024-12-31
Moleculin Biotech, Inc.
Annamycin
Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company developing drug candidates for highly resistant tumors and viruses. Its lead product, Annamycin, is in Phase 1/2 studies, and it also works on other candidates targeting brain tumors, pancreatic cancer, and COVID-19.
Symbol: MBRX
Recent Price: $1.79
Industry: Biotechnology
CEO: Mr. Walter V. Klemp
Sector: Healthcare
Employees: 18
Address: 5300 Memorial Drive, Houston, TX 77007
Phone: 713 300 5160
Last updated: 2024-12-31
Maravai LifeSciences Holdings, Inc.
Nucleic Acids and Biologics Safety Testing Products
Maravai Life Sciences Holdings, Inc. is a life sciences company that provides products for drug therapies, diagnostics, novel vaccines, and research on human diseases, serving both the United States and international markets.
Symbol: MRVI
Recent Price: $5.51
Industry: Biotechnology
CEO: Mr. William E. Martin III
Sector: Healthcare
Employees: 580
Address: 10770 Wateridge Circle, San Diego, CA 92121
Phone: 858 546 0004
Last updated: 2024-12-31
Cassava Sciences, Inc.
simufilam
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead product candidate, simufilam, is a small molecule drug, recently completed Phase 2b clinical trial. The company also develops Sava Dx, a diagnostic to detect Alzheimer's disease.
Symbol: SAVA
Recent Price: $2.40
Industry: Biotechnology
CEO: Mr. Richard Jon Barry
Sector: Healthcare
Employees: 29
Address: 7801 North Capital of Texas Highway, Austin, TX 78731
Phone: 512 501 2444
Last updated: 2024-12-31
Sagimet Biosciences Inc.
Denifanstat
Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics called fatty acid synthase (FASN) inhibitors for diseases caused by dysfunctional lipid metabolism pathways. Its lead drug candidate, Denifanstat, targets nonalcoholic steatohepatitis and acne. The company is also working on FASN inhibitors for cancer treatment.
About | Contact | Careers | About | Directors | About | About | Contact | About | About | About | About | Contact | ESG | Events | About | Careers
Symbol: SGMT
Recent Price: $4.72
Industry: Biotechnology
CEO: Mr. David A. Happel
Sector: Healthcare
Employees: 8
Address: 155 Bovet Road, San Mateo, CA 94402
Phone: 650-561-8600
Leadership
- George Kemble, PhD, Executive Chairman of the Board
- David Happel, Chief Executive Officer
- Anne Phillips, MD,
- Beth Seidenberg, MD,
- Elizabeth Grammer, Esq,
- Jennifer Jarrett,
- Merdad Parsey, MD, PhD,
- Paul Hoelscher,
- Tim Walbert,
Last updated: 2024-12-31
Simulations Plus, Inc.
Gastro Plus
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, utilizing artificial intelligence and machine learning technology to predict molecular properties.
About | About | Contact | About | About | About | About | About | About | About | News | Leadership | Contact | Careers | Careers | About | About | About | About
Symbol: SLP
Recent Price: $27.94
Industry: Medical - Healthcare Information Services
CEO: Mr. Shawn M. O'Connor
Sector: Healthcare
Employees: 243
Address: 42505 Tenth Street West, Lancaster, CA 93534-7059
Phone: 661 723 7723
Leadership
- Shawn O’Connor, Chief Executive Officer
- Will Frederick, Chief Financial Officer and Chief Operating Officer
- Daniel Szot, Chief Revenue Officer
- Josh Fohey, Sr. VP, Operations
- Jenna Rouse, President
- Jill Fiedler-Kelly, President
- John A. DiBella, President
- Jonathan Chauvin, President
- Murry Alper, President
- Sandra Suarez Sharp, President
- Steven Chang, President
- Amparo de la Peña, VP, PMx Services
- Andreas Krause, Chief Scientific Officer
- Andrew Rokitka, VP, Information Technology
- Bud Nelson, VP, Corp. Cnsl. & PDPO
- Christina Hendrickson, Director, Corp. Marketing
- Daniel Hoeft, Vice President, Finance
- David Miller, VP, Cheminformatics
- John Bartels, Vice President, Technology
- Julie Cook, VP, Biz. Integration & TF
Last updated: 2024-12-31
Adaptive Biotechnologies Corporation
immunoSEQ
Adaptive Biotechnologies Corporation is a commercial-stage company that develops an immune medicine platform for diagnosing and treating various diseases, including COVID-19 and lymphoid cancers.
Leadership | Contact | About | About | About | About | Careers | Careers | About | About | About | About | About
Symbol: ADPT
Recent Price: $6.11
Industry: Biotechnology
CEO: Mr. Chad M. Robins M.B.A.
Sector: Healthcare
Employees: 709
Address: 1165 Eastlake Avenue East, Seattle, WA 98109
Phone: 206 659 0067
Last updated: 2024-12-31
Seelos Therapeutics, Inc.
SLS-002, SLS-005, SLS-006, SLS-007, SLS-008, SLS-004, SLS-010
Seelos Therapeutics, Inc. is focused on developing and commercializing therapeutics for central nervous system, respiratory, and other disorders, with lead programs targeting major depressive disorders, amyotrophic lateral sclerosis, Sanfilippo syndrome, and Parkinson's disease.
Symbol: SEEL
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Raj Mehra J.D., Ph.D.
Sector: Healthcare
Employees: 8
Address: 300 Park Avenue, New York, NY 10022
Phone: 646 293 2100
Last updated: 2024-12-31